The Centers for Medicare and Medicaid Services ("CMS") published a final notice outlining the processes and procedures for the Transitional ...

Senators grilled Robert F. Kennedy Jr. on if and how he would reform Medicaid and Medicare during his first confirmation ...

CMS ultimately selected to test three models with the ... would have had Medicare pay less for drugs that receive accelerated ...

President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals ...

The Trump administration’s Centers for Medicare & Medicaid Services (CMS) has signaled that it will be revamping the process ...

In 2025, we may see radical top-down changes to our healthcare system as new heads of the NIH – National Institutes of Health ...

these products are not considered generic versions and are not approved by the Food and Drug Administration. CMS had until Feb. 1 to publish the next round of drugs chosen for Medicare negotiation.

Through the issuance of Inauguration Day executive orders, the Trump Administration signaled its apparent intent to tackle ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

A senior official with U.S. Department of Health and Human Services on Tuesday instructed agencies, such as the Food and Drug Administration and Centers ... including the FDA, CDC, CMS and the ...

Robert F. Kennedy Jr. said he would follow the Trump administration’s orders on prescription drug price negotiations, a ...